Thursday, June 25, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 867 of 1,261

  1. US 8461295

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  2. US 8461203

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  3. US 8461192

    Method of selectively inhibiting PKCiota

    The United States of America—Department of Veterans Affairs · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  4. US 8461172

    Solid forms and process for preparing

    Corcept Therapeutics Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  5. US 8461187

    Multiple PPI dosage form

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  6. US 8461154

    Methods of utilizing arylpiperazine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  7. US 8461156

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  8. US 8461155

    Sclerostin and the inhibition of WNT signaling and bone formation

    UNIVERSITY OF CONNECTICUT · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  9. US 8460864

    Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

    PTC THERAPEUTICS, INC. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  10. US 8460675

    Viral chemokine-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  11. US 8460660

    Anti-mesothelin antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  12. US 8460693

    Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent

    ATRIUM MEDICAL CORPORATION · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  13. US 8461339

    Pharmaceutical compounds

    SENTINEL ONCOLOGY LIMITED · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  14. US 8460651

    Methods of treating amyotrophic lateral sclerosis (ALS)

    The Regents of the University of California · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  15. US 8460643

    Formulation for prophylaxis of oral cavity diseases

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU “WELDUP” · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  16. US 8458818

    Elastomeric gloves and methods of making

    Sentinal Engineering (M) SDN BHD · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  17. US 8461298

    Compositions and methods for modification of biomolecules

    The Regents of the University of California · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  18. EP 2599478

    Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon

    ACINO AG [DE] · Granted Jun 5, 2013 · Expires May 31, 2033

    granted

  19. US 8455499

    Alkyne antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  20. US 8454946

    N-maleimidyl polymer derivatives

    Nektar Therapeutics · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  21. US 8454965

    Method for the treatment of multiple sclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  22. US 8455454

    miR 204, miR 211, their anti-miRs, and therapeutic uses of same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  23. US 8455435

    Remedies for ischemia

    Ludwig-Maximilians-Universitat Munchen · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  24. US 8455010

    Product and method for producing an immune system supplement and performance enhancer

    Reoxcyn Discoveries Group, Inc. · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.